Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2011-07-05
2011-07-05
Hartley, Michael G (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S434000, C424S464000
Reexamination Certificate
active
07972622
ABSTRACT:
Consumable or dissolvable tablets are manufactured by supplying a liquid containing a biodissolvable carrier to an outlet; establishing an electric field between the outlet and a support surface to cause liquid issuing from the outlet to form at least one fiber or fibrils of the biodissolvable carrier which fiber or fibrils deposit(s) onto the surface to form a fiber web or mat; separating the web or mat into a plurality of individual tablets; and incorporating at least one active ingredient on or in the tablets.
REFERENCES:
patent: 4043331 (1977-08-01), Martin et al.
patent: 4044404 (1977-08-01), Martin et al.
patent: 4197289 (1980-04-01), Sturzenegger et al.
patent: 4704436 (1987-11-01), Barabas
patent: 4855326 (1989-08-01), Fuisz
patent: 4878908 (1989-11-01), Martin et al.
patent: 4946684 (1990-08-01), Blank et al.
patent: 5024671 (1991-06-01), Tu et al.
patent: 5215755 (1993-06-01), Roche et al.
patent: 5229164 (1993-07-01), Pins
patent: 5298261 (1994-03-01), Pebley et al.
patent: 5311884 (1994-05-01), Scopelianos
patent: 5320855 (1994-06-01), Roche et al.
patent: 5322698 (1994-06-01), Kovacs et al.
patent: 5376116 (1994-12-01), Polar
patent: 5466464 (1995-11-01), Masaki et al.
patent: 5501861 (1996-03-01), Makino et al.
patent: 5522879 (1996-06-01), Scopelianos
patent: 5567439 (1996-10-01), Myers et al.
patent: 5575818 (1996-11-01), Pinchuk
patent: 5632772 (1997-05-01), Alcime et al.
patent: 5639278 (1997-06-01), Dereume et al.
patent: 5724004 (1998-03-01), Reif et al.
patent: 5736152 (1998-04-01), Dunn
patent: 5762961 (1998-06-01), Roser et al.
patent: 5866163 (1999-02-01), Myers et al.
patent: 5869098 (1999-02-01), Misra et al.
patent: 5980941 (1999-11-01), Raiden et al.
patent: 6074688 (2000-06-01), Pletcher et al.
patent: 6423346 (2002-07-01), Hansen et al.
patent: 6465009 (2002-10-01), Liu et al.
patent: 6709669 (2004-03-01), Murray et al.
patent: 0 019 929 (1980-12-01), None
patent: 0542514 (1993-05-01), None
patent: 2 335 206 (1977-07-01), None
patent: WO 90 06969 (1990-06-01), None
patent: WO 98/03267 (1998-01-01), None
patent: WO 98 03267 (1998-01-01), None
patent: WO 01/54667 (2001-01-01), None
Bhowmik, D. et al., “Fast Dissolving Tablet: An Overview,” Journal of Chemical and Pharmaceutical Research, vol. 1(1) (2009) pp. 163-177.
“Guidance for Industry—Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms Containing Certain Active Moieties/Active Ingredients Based on a Biopharmaceuticals Classification System,” U.S. Department of Health and Human Services, Food and Drug Administration (Jan. 1999) pp. 1-14.
Porter, S. C., “Novel Drug Delivery: Review of Recent Trends with Oral Solid Dosage Forms,” American Pharmaceutical Review, pp. 28-35.
Seager, H., “Drug-delivery Products and the Zydis Fast-dissolving Dosage Form,” J. Pharm. Pharmacol., vol. 50 (1998) pp. 375-382.
Supervía, A., et al., “Piroxicam fast-dissolving dosage form vs diclofenac sodium in the treatment of acute renal colic: a double-blind controlled trial,” British Journal of Urology, vol. 81 (1998) pp. 27-30.
Coffee Ronald Alan
Davies David Neville
Pirrie Alastair Bruce
Battelle (Memorial Institute)
Frost Brown Todd LLC
Hartley Michael G
Samala Jagadishwar R
LandOfFree
Method and apparatus for manufacturing dissolvable tablets does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and apparatus for manufacturing dissolvable tablets, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and apparatus for manufacturing dissolvable tablets will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2701416